The epitranscriptome landscape of small noncoding RNAs in stem cells.


Journal

Stem cells (Dayton, Ohio)
ISSN: 1549-4918
Titre abrégé: Stem Cells
Pays: England
ID NLM: 9304532

Informations de publication

Date de publication:
01 10 2020
Historique:
received: 21 11 2018
revised: 04 05 2020
accepted: 11 05 2020
pubmed: 1 7 2020
medline: 7 7 2021
entrez: 30 6 2020
Statut: ppublish

Résumé

Stem cells (SCs) are unique cells that have an inherent ability to self-renew or differentiate. Both fate decisions are strongly regulated at the molecular level via intricate signaling pathways. The regulation of signaling networks promoting self-renewal or differentiation was thought to be largely governed by the action of transcription factors. However, small noncoding RNAs (ncRNAs), such as vault RNAs, and their post-transcriptional modifications (the epitranscriptome) have emerged as additional regulatory layers with essential roles in SC fate decisions. RNA post-transcriptional modifications often modulate RNA stability, splicing, processing, recognition, and translation. Furthermore, modifications on small ncRNAs allow for dual regulation of RNA activity, at both the level of biogenesis and RNA-mediated actions. RNA post-transcriptional modifications act through structural alterations and specialized RNA-binding proteins (RBPs) called writers, readers, and erasers. It is through SC-context RBPs that the epitranscriptome coordinates specific functional roles. Small ncRNA post-transcriptional modifications are today exploited by different mechanisms to facilitate SC translational studies. One mechanism readily being studied is identifying how SC-specific RBPs of small ncRNAs regulate fate decisions. Another common practice of using the epitranscriptome for regenerative applications is using naturally occurring post-transcriptional modifications on synthetic RNA to generate induced pluripotent SCs. Here, we review exciting insights into how small ncRNA post-transcriptional modifications control SC fate decisions in development and disease. We hope, by illustrating how essential the epitranscriptome and their associated proteome are in SCs, they would be considered as novel tools to propagate SCs for regenerative medicine.

Identifiants

pubmed: 32598085
doi: 10.1002/stem.3233
pmc: PMC7586957
doi:

Substances chimiques

RNA, Small Untranslated 0
RNA-Binding Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1216-1228

Informations de copyright

©2020 The Authors. Stem Cells published by Wiley Periodicals LLC. on behalf of AlphaMed Press 2020.

Références

RNA. 2017 Mar;23(3):317-332
pubmed: 27881476
Genomics Proteomics Bioinformatics. 2017 Jun;15(3):187-195
pubmed: 28602844
Front Med (Lausanne). 2015 Sep 08;2:64
pubmed: 26442266
Mol Cell. 2018 Sep 20;71(6):986-1000.e11
pubmed: 30197299
Am J Transl Res. 2010 Mar 25;2(2):170-80
pubmed: 20407606
Trends Cancer. 2018 Mar;4(3):207-221
pubmed: 29506671
Genes Dev. 2012 Nov 1;26(21):2361-73
pubmed: 23124062
RNA Biol. 2010 Mar-Apr;7(2):192-204
pubmed: 20215871
Cell Rep. 2019 Aug 13;28(7):1703-1716.e6
pubmed: 31412241
PLoS Genet. 2011 Dec;7(12):e1002403
pubmed: 22144916
Tissue Eng Part A. 2019 Jan;25(1-2):91-112
pubmed: 29661055
Cell. 2014 Sep 25;159(1):148-162
pubmed: 25219674
Nat Struct Mol Biol. 2006 Jan;13(1):13-21
pubmed: 16369484
Cell Rep. 2013 May 30;3(5):1398-1406
pubmed: 23623502
Atherosclerosis. 2011 Dec;219(2):468-74
pubmed: 21945499
EJIFCC. 2018 Nov 07;29(3):221-226
pubmed: 30479608
Nat Biotechnol. 2013 May;31(5):458-64
pubmed: 23604283
Nat Commun. 2018 Jun 20;9(1):2418
pubmed: 29925839
FEBS Lett. 2018 Sep;592(17):2828-2844
pubmed: 30058219
EMBO J. 2014 Sep 17;33(18):2020-39
pubmed: 25063673
Nucleic Acids Res. 2012 Jul;40(13):6001-15
pubmed: 22492625
EMBO J. 2017 Nov 2;36(21):3194-3211
pubmed: 29030484
Biomaterials. 2018 Feb;156:172-193
pubmed: 29197748
Cell Stem Cell. 2016 Aug 4;19(2):177-191
pubmed: 27292188
Cell. 2009 May 15;137(4):606-8
pubmed: 19450510
Infect Agent Cancer. 2015 Nov 30;10:42
pubmed: 26622315
Nat Commun. 2018 Jul 17;9(1):2761
pubmed: 30018356
Genome Biol. 2017 Jan 5;18(1):1
pubmed: 28077169
Bioessays. 2018 Feb;40(2):
pubmed: 29280160
Stem Cell Reports. 2017 Jan 10;8(1):112-124
pubmed: 28041877
Nat Med. 2014 Aug;20(8):814-21
pubmed: 25100527
Yale J Biol Med. 2009 Sep;82(3):121-4
pubmed: 19774126
Int J Cell Biol. 2016;2016:6940283
pubmed: 27516776
Cell Rep. 2013 Jul 25;4(2):255-61
pubmed: 23871666
RNA Biol. 2008 Jul-Sep;5(3):135-9
pubmed: 18758244
Cell Rep. 2015 Oct 27;13(4):854-863
pubmed: 26489470
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Oct;1863(10):1323-1330
pubmed: 30305247
Cell Res. 2018 Sep;28(9):904-917
pubmed: 30065315
Carcinogenesis. 2012 Jan;33(1):68-76
pubmed: 22072622
Stem Cells. 2020 Oct 1;38(10):1216-1228
pubmed: 32598085
Nature. 2018 May;557(7705):351-358
pubmed: 29769672
Nat Rev Cancer. 2017 Jun;17(6):381-392
pubmed: 28416802
Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14452-9
pubmed: 26598661
Cell. 2017 Jun 29;170(1):61-71.e11
pubmed: 28666125
Adv Exp Med Biol. 2013;786:329-51
pubmed: 23696365
EMBO J. 2015 Sep 14;34(18):2350-62
pubmed: 26271101
Nucleic Acids Res. 2017 Jul 7;45(12):7401-7415
pubmed: 28472312
Mol Cell. 2018 Jul 19;71(2):244-255.e5
pubmed: 29983320
Front Genet. 2017 Mar 28;8:31
pubmed: 28400788
Nat Rev Genet. 2009 Feb;10(2):94-108
pubmed: 19148191
PLoS One. 2015 Feb 27;10(2):e0118438
pubmed: 25723394
Nucleic Acids Res. 2018 Jan 4;46(D1):D303-D307
pubmed: 29106616
World J Gastroenterol. 2011 Nov 14;17(42):4711-7
pubmed: 22180714
Nat Rev Mol Cell Biol. 2009 Feb;10(2):116-25
pubmed: 19165214
Cell Rep. 2015 Mar 31;10(12):2069-82
pubmed: 25818294
PLoS Biol. 2019 Jun 14;17(6):e3000297
pubmed: 31199786
Nat Med. 2017 Nov;23(11):1369-1376
pubmed: 28920958
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):337-42
pubmed: 24367095
Trends Mol Med. 2008 Sep;14(9):400-9
pubmed: 18674967
Stem Cells Int. 2018 Oct 10;2018:3256524
pubmed: 30405719
Development. 2016 Nov 1;143(21):3871-3881
pubmed: 27803056
Oncotarget. 2016 Aug 16;7(33):53895-53902
pubmed: 27259993
Science. 2016 Jan 15;351(6270):282-5
pubmed: 26816380
Protein Cell. 2016 Feb;7(2):100-13
pubmed: 26399619
Nature. 2016 Jun 15;534(7607):335-40
pubmed: 27306184
Stem Cell Res. 2015 Sep;15(2):305-11
pubmed: 26209818
Cell. 2015 Sep 10;162(6):1299-308
pubmed: 26321680
EMBO Rep. 2017 Nov;18(11):2004-2014
pubmed: 29051200
Nature. 2017 Sep 14;549(7671):273-276
pubmed: 28869969
Lab Invest. 2014 Dec;94(12):1370-81
pubmed: 25286029
Gut. 2015 Dec;64(12):1936-48
pubmed: 25887381
Nature. 2017 Jan 19;541(7637):371-375
pubmed: 28002401
Nat Chem Biol. 2014 Feb;10(2):93-5
pubmed: 24316715
Nat Genet. 2009 Jun;41(6):696-702
pubmed: 19412177
Int J Mol Sci. 2013 Jul 15;14(7):14744-70
pubmed: 23860209
Genomics Proteomics Bioinformatics. 2017 Jun;15(3):154-163
pubmed: 28533023
Curr Genomics. 2015 Oct;16(5):319-26
pubmed: 27047252
Nat Struct Mol Biol. 2016 Feb;23(2):98-102
pubmed: 26840897
Cell Death Dis. 2017 May 18;8(5):e2796
pubmed: 28518139
Mol Cancer. 2015 May 01;14:98
pubmed: 25928322
Development. 2016 Feb 1;143(3):530-9
pubmed: 26718004
Cell. 2012 Oct 12;151(2):278-88
pubmed: 23063121
Methods. 2016 Sep 1;107:63-72
pubmed: 26968262
Cancer Lett. 2017 Dec 28;411:27-34
pubmed: 28974449
Cell Stem Cell. 2014 Jan 2;14(1):40-52
pubmed: 24239284
Nat Commun. 2019 Jun 11;10(1):2550
pubmed: 31186410
Stem Cell Res Ther. 2017 May 11;8(1):110
pubmed: 28494789
Cell Stem Cell. 2014 Dec 4;15(6):707-19
pubmed: 25456834
NPJ Breast Cancer. 2018 Aug 6;4:20
pubmed: 30109262
PLoS One. 2016 Jun 06;11(6):e0156953
pubmed: 27270731
RNA. 2008 Jun;14(6):1174-86
pubmed: 18456843
Mol Cell Biol. 2013 Apr;33(8):1561-70
pubmed: 23401851
Nat Cell Biol. 2019 Jun;21(6):700-709
pubmed: 31061465
NPJ Regen Med. 2018 Sep 17;3:15
pubmed: 30245848
PeerJ. 2015 Oct 20;3:e1332
pubmed: 26623179
Nat Struct Mol Biol. 2018 May;25(5):357-364
pubmed: 29662218
Cell. 2018 May 17;173(5):1204-1216.e26
pubmed: 29628141
Cell Stem Cell. 2013 Apr 4;12(4):395-406
pubmed: 23561442
Dev Dyn. 2018 Jan;247(1):75-84
pubmed: 28766845
RNA Biol. 2013 Apr;10(4):553-63
pubmed: 23563448
PLoS Genet. 2012;8(6):e1002751
pubmed: 22685420
Trends Mol Med. 2016 Dec;22(12):1025-1034
pubmed: 27840066
J Cell Mol Med. 2016 Sep;20(9):1779-88
pubmed: 27097729
Trends Cell Biol. 2015 Mar;25(3):137-47
pubmed: 25484347
Nature. 2015 Mar 26;519(7544):482-5
pubmed: 25799998
Blood. 2013 Apr 11;121(15):2875-81
pubmed: 23390194
Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11467-72
pubmed: 25049417

Auteurs

James M W R McElhinney (JMWR)

Department of Biomedical Engineering, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates.

Ayesha Hasan (A)

Department of Biomedical Engineering, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates.

Abdulrahim A Sajini (AA)

Department of Biomedical Engineering, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH